Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford’s Primate Neuroscience research group and Biomedical Services team have been recognised for their openness and public engagement at Understanding Animal Research’s (UAR) fourth annual Openness Awards and the 81st Stephen Paget memorial lecture.

Image courtesy of Shutterstock

The Award for a Public Engagement Activity was presented jointly to the University of Oxford, MRC Harwell Institute, The Pirbright Institute and the University of Bristol, for coming together to open their labs to 3D cameras in order that the 360 degree Virtual Lab Animal Tour could be made.

Maria Martinez, the Primate Welfare Officer from the Biomedical Services Department said: ‘While animal research is necessary, is it essential for scientific, veterinary and animal care staff to continue to work closely together to maintain the highest standards of animal welfare. The virtual tour has been a great opportunity for Oxford to openly share the type research conducted in primates and the welfare standards that we maintain for our animals.'

Read more (University of Oxford website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.